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 Acetone is normally present in the body at low levels (United States Public Health 
Service, 1994).  High levels of acetone can be toxic, leading to coma and even death 
(Levine, 2006).   At the same time, an increased blood-acetone concentration could 
indicate a toxic condition, such as diabetic ketoacidosis.  Acetone levels may also be 
elevated as a result of ketogenic diets (Kalapos, 2003).  
Acetone has a high vapor pressure, or volatility, which means that it evaporates 
readily.  Because acetone is volatile, quantitation in biological samples can be 
challenging.  Headspace Gas Chromatography with Flame Ionization Detection (HS-
GC/FID) has been successfully utilized for the analysis of volatile chemicals (Barua, Chi, 
Fitzpatrick, Gillard, & Kostyniak, 2008).  The HS autosampler allows for the analysis of 
volatiles in blood, the GC separates and identifies the sample components, and the FID 
measures each component (Levine, 2006).    
 The purpose of this research project was to develop and validate a method for the 
quantitation of acetone in blood using HS-GC/FID.  Method validation serves as a quality 
assurance measure and is required for accredited laboratories (Federal Bureau of 
Investigation, 2009).  The Portland Metropolitan Forensic Laboratory (Portland Lab) is
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accredited through the American Society of Crime Laboratory Directors - Laboratory 
Accreditation Board (ASCLD-LAB), one of the main national accrediting bodies for 
forensic laboratories.  Without a validated method for acetone quantitation on-site, the 
Portland Lab had to subcontract acetone quantitations to a laboratory with an operational 
validated method, as per ASCLD-LAB standards.  
Precision, accuracy, selectivity, sensitivity, repeatability, and stability are the key 
aspects of a method validation (Federal Bureau of Investigation, 2009).  Therefore, the 
following items were included in this method development: preparation of standards and 
positive controls, testing the necessity of using salts, establishment of a suitable internal 
standard concentration, determination of an appropriate sample size, limit of detection 
calculation, establishment of the linear dynamic range, checking for carryover, checking 
the stability of samples containing acetone, and method validation including postmortem 
case samples.   
Standards are used to create a calibration curve from which the concentrations of 
samples and controls may be determined.  As such, the standard concentrations should be 
based on known normal, toxic, and disease-state acetone levels. Testing acetone 
standards from two different sources will confirm that the provided standards are pure 
and that the instrument is functioning properly while determining the mean, standard 
deviation, and percent error for each of the acetone standards will test for accuracy and 
precision.  The correlation coefficient from the calibration curve measures how well the 
data fits the line and should be as close to one as possible (Levine, 2006).  The Portland 
Lab requires that the correlation coefficient be at or above 0.99 in their validated 
quantitation methods (Oregon State Police Forensic Services Division, 2008).  
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When preparing standard calibration curves, generally a ratio of analyte to 
internal standard peak area is plotted on the y-axis with analyte concentration on the x-
axis.  The peak area ratio is an accurate reflection of the total amount of a compound in 
the original sample.  Peak height ratios are sometimes used instead of peak area, but only 
when the peaks are broad or overlapping (Levine, 2006). 
Salts can affect the degree to which a volatile partitions into the headspace (Kolb 
& Ettre, 2006).  A greater amount of volatile present in the headspace means there is 
more analyte available for analysis.  Therefore, salts have the potential of increasing the 
sensitivity for detecting certain analytes. 
The Portland Lab uses 1.5 mL of 0.05% (v/v) n-propanol in water internal-
standard solution for blood-alcohol analysis.  The same concentration was used as the 
starting point for the internal standard concentration experiment.  An appropriate internal 
standard concentration will be low enough to allow peak detection at low analyte 
concentrations.  The amount of internal standard added should also result in detectable 
and reproducible peak regardless of the sample characteristics like clots.  A high internal 
standard concentration will result in a large internal standard peak, making the analyte 
peak appear smaller.  Thus, internal standard concentration can affect the visibility of the 
analyte peak. 
Sample size may affect peak visibility and/or accuracy of calculated analyte 
concentrations.  The smallest sample size that still produces accurate results should be 
used.  Using a method with a small sample volume will ensure that enough of the sample 
is present for duplicate analyses.  This also preserves samples for subsequent testing by 
outside laboratories if needed.  
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The limit of detection corresponds to the lowest detectable signal.  Thus, a 
method with a lower limit of detection can "see" a smaller concentration of drug and 
therefore has a higher sensitivity.  The limit of detection can be estimated from blank 
samples as mean plus three times the standard deviation of the noise (Levine, 2006). A 
blank sample is not expected to contain the analyte of interest.  The mean concentration 
of the blank samples is determined by integrating the chromatogram along the analyte’s 
expected retention time range.  Generally, the mean is close to zero.  
A method should at least be linear over the expected normal and toxic ranges of 
an analyte.  The linear dynamic range identifies the concentrations between which an 
analyte may be quantitated.  Any quantitations performed outside the linear dynamic 
range will not produce accurate or precise results (Skoog, Holler, & Crouch, 2007).  In 
any case, quantitative assays require that the unknown value be determined in the linear 
range of the sample curve for accurate quantitation and the sample should be compared 
with standards at higher and lower values within that particular analysis. 
Carryover occurs when a sample containing a large amount of analyte is not 
completely eluted from the column and is “carried over” to the next sample. The result of 
carryover from one sample to another is artificially high concentrations calculated for 
samples that contained the analyte already and false-positives in samples that actually had 
no analyte whatsoever (Levine, 2006). 
Validation using controls and actual postmortem case samples ensures that the 
method leads to accurate and precise results with high degrees of sensitivity and 
selectivity.  Accuracy is measured by calculating the percent error between expected and 
calculated control concentrations.  Standard deviations can be used to measure the 
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method’s precision.  The limits of detection and quantitation illustrate the sensitivity of 
the method while baseline separation of several components can demonstrate selectivity 
(Federal Bureau of Investigation, 2009).   
Sample degradation may occur over time as a result of storage temperature 
(Levine, 2006).  Samples are generally stored in the refrigerator but other options include 
storage in the freezer or at room temperature.  These storage alternatives could vastly 
increase sample storage space.  
With the acetone quantitation parameters optimized and the method validated, 
forensic toxicologists at the Portland Metropolitan Forensic Lab may conduct acetone 
quantitations themselves, rather than having to send the samples to another laboratory for 
analysis.  Having a validated acetone-quantitation method on-site may save time and 
money.   In terms of time, the Portland Lab will be able to control when acetone-
containing samples are analyzed.  The costs associated with an in-house acetone-
quantitation method include analysts’ salaries, instrument maintenance, training, and 







REVIEW OF LITERATURE 
II. A.  Acetone 
Acetone is a volatile chemical with a pungent, “characteristic odor and sweetish 
taste” (O’Neil, Smith, Heckelman, & Obenchain, Jr., 2001).  The chemical structure of 
acetone is shown in Figure 1. 
 
Figure 1. Chemical Structure of Acetone 
Volatiles have the ability of existing in "a form that may be inhaled" (Levine, 2006).  
Therefore, acetone and other volatile chemicals may also be referred to as inhalants.  
Inhalant abuse is common among teenagers and is “one of the most prevalent drug abuse 
problems in the world” (Bowen, Daniel, & Balster, 1999).  According to the 2007 
National Survey of Drug Use and Health, 775,000 people over the age of 12 had abused 
inhalants for the first time in that year while 66.7% of those first-time abusers were under 
the age of 18 (National Institute on Drug Abuse, 2009).   Acetone abusers desire euphoria 
and loss of inhibition, but other effects include confusion and vomiting as well as 
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irritation of the nose, throat, trachea, and lungs (United States Public Health Service, 
1994).  A full description of the toxic effects of acetone may be found in section II. A. ii.   
Low concentrations of acetone, an endogenous ketone, build up in the body as a 
result of the breakdown of fat.  The mechanism of fat breakdown, or lipolysis, is 
generally beta-oxidation to acetyl-CoA.  Acetyl-CoA can then either enter the Citric Acid 
Cycle or it can be converted to acetone and two other ketones via ketogenesis (Berg, 
Tymoczko, & Stryer, 2002).  Ketogenesis generally occurs in the liver.  After excretion 
into the blood, ketones are carried throughout the body to be used as a source of energy 
(United States Public Health Service, 1994).  In the blood, acetone concentrations around 
1 mg/dL are considered normal (Ashley, 1994).    
When acetone is inhaled, the majority is absorbed after 15 minutes (United States 
Public Health Service, 1994).  Acetone is distributed to tissues and organs with high 
water content.  The volume of distribution for acetone, or the amount of body water in 
which the chemical is distributed if the whole dose remains in the blood (Levine, 2006), 
is 0.8 L/kg (Baselt, 2000), which is consistent with other hydrophilic substances.  
Acetone is excreted from the body into urine and air, either as parent compound or as 
metabolite(s).  Inhaled acetone is mainly eliminated via the lungs.  The half-life of 
acetone is between 3 and 6 hours (Baselt, 2000).   
 
II. A. i.  Metabolism 
Acetone metabolism does not depend on the route of exposure (i.e. naturally-
occurring acetone versus inhaled acetone), and generally takes place in the liver.  
Acetone is intermediately catabolized to glucose via gluconeogenesis (Figure 2).  
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Glucose is then broken down via glycolysis to produce acetone’s final metabolic products 
of carbon dioxide and adenosine triphosphate (ATP).  ATP is a major energy source in 
cellular biology and is often referred to as the “currency of energy” (Berg, et al., 2002).   
 
Figure 2.  Intermediary Metabolic Pathways of Acetone (Kalapos, 2003) 
As seen in Figure 2, the primary step in acetone catabolism to glucose is oxidation 
to acetol.  This is the rate-limiting step (United States Public Health Service, 1994).  In 
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the liver, acetol is further broken down to methylglyoxal and ultimately produces 
glucose.  When metabolism takes place outside the liver, acetol is converted to 1,2-
propanediol then lactaldehyde then lactate and finally glucose.   Glucose can also be 
synthesized from acetate and formate, the third gluconeogenic pathway of acetone 
metabolism (Kalapos, 2003).  Metabolism to acetate and formate occurs at a rate of 1 to 3 
mg/kg/hr (Baselt, 2000).   However, diabetes and fasting can “alter the pattern of 
metabolism” (United States Public Health Service, 1994).  Other factors that affect the 
rate of metabolism include "respiratory rate, blood flow, proportion of body fat, and 
metabolic clearance rate" (Levine, 2006). 
 Metabolites are eliminated in both exhaled air and urine while acetone itself may 
also be eliminated in exhaled air.  The average blood to breath acetone concentration 
ratio is 330, with a range from 322 to 339 (Haggard, Greenberg, & Turner, 1944).  
Metabolism is the chief route of elimination and accounts for 70 to 80 percent of acetone 
elimination from the body (United States Public Health Service, 1994).   
 
II. A. ii. Toxicology 
 Establishing a toxic level of acetone and other volatile chemicals can be difficult 
due to individual variation in metabolism and other factors.  Chronic acetone abusers may 
develop a high threshold.  For example, Levine reported a toxic concentration for the 
volatile chemical toluene of 70 mg/L while the majority of deaths attributed to toluene 
inhalation occurred at concentrations less than 5 mg/L (2006).  Death after acetone (or 
another volatile chemical) intoxication is often a result of cardiac arrest or pulmonary 
complications, including asphyxiation and suffocation.   
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Acetone is toxic in the blood at levels greater than 33 mg/dL (Burns et al., 1998).  
Symptoms include confusion, vomiting, drowsiness, and hyperventilation (Sulway & 
Malins, 1970).  Larger doses can lead to convulsions, coma, or death.  Prolonged abuse of 
acetone as an inhalant negatively affects the central nervous system.  Loss of 
coordination, loss of cognitive function, and gait disturbance are only some of the effects.  
Worse still, volatile chemicals such as acetone can lead to a decrease in brain mass 
because they "literally dissolve brain cells" (Levine, 2006).  
 
II. A. iii.  Ketoacidosis/ketogenic diets 
According to Deng, “acetone is an important volatile disease marker” (2004).  
However, acetone is not the causative agent in disease.  Acetone levels are elevated in 
people with type-I diabetes, especially during ketoacidosis.  Ketoacidosis occurs when 
diabetes is uncontrolled leading to an increase in acidic ketone concentrations, including 
acetone, with the final result of a lowered serum pH (Miekisch, Schubert, Vagts, & 
Geiger, 2001).  The increased acetone concentrations can be “traced to the increased 
mobilization and utilization of free fatty acids in the liver” (United States Public Health 
Service, 1994).  Ketoacidosis can cause diabetic coma and/or death.    
In controlled diabetes, the blood acetone level is normally less than 3 mg/dL 
(Jones, Sagarduy, Ericsson, & Arnqvist, 1993).  Ketoacidotic individuals will exhibit a 
higher blood acetone level.  During ketoacidosis, the concentration of acetone may range 
from 10 to 70 mg/dL (Ramu, Rosenbaum, & Blaschke, 1978). 
Acetone levels can also be higher than average for people on ketogenic diets.  
Ketogenic diets are low in carbohydrates so fat is the primary source of energy.  They 
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have been implemented for the prevention of epilepsy (Kalapos, 2006).   Such diets 
elevate the level of acetone in the brain.  These elevated acetone levels are what make 
ketogenic diets effective in controlling epilepsy, although the mechanism is not well 
understood (Likhodii, 2003). 
Diabetes and ketogenic diets “place high energy demands upon the body which 
result in increased fatty acid utilization and higher than normal blood levels of acetone” 
(United States Public Health Service, 1994).  Children and pregnant women also have 
higher-than-average acetone blood levels due to their higher energy expenditures.  
 
II. B. Validation 
 Validation is used to evaluate a quantitation procedure for “efficacy and reliability 
for forensic casework analysis” (Federal Bureau of Investigation, 2009).  For 
developmental validation, the appropriate conditions for analysis as well the limitations 
of the method must be determined.  Precision, accuracy, specificity, and sensitivity are 
the key components to be investigated during development.  Stability and reproducibility 
should also be considered.   
Precision is a gauge of the variability between samples while accuracy is a 
“measure of the degree to which the experimental mean agrees with the true or theoretical 
concentration” (Levine, 2006).  Both precision and accuracy are considered when 
determining the error associated with a method.  
Accurate gas chromatographic quantitative methods generally require the 
inclusion of an internal standard with each sample analyzed.  An internal standard will 
improve precision and accuracy by normalizing any variations in recovery due to analyte 
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behavior during processing and analysis.  Prior to analysis, an equal amount of internal 
standard must be added to each prepared sample, standard, and control vial.  An 
appropriate internal standard should be similar in structure to the analyte so that it 
behaves similarly during chemical analysis.  The internal standard should not be expected 
to be present in the sample and should be resolved chromatographically (i.e. have a 
different retention time than the analyte).  Taking these qualifications into account, n-
propanol should serve as a good internal standard for the quantitation of acetone in blood 
(Figure 3).   
 
Figure 3.  Chemical Structure of n-Propanol   
Methods capable of measuring an analyte while differentiating that analyte from 
other compounds present in the sample are considered specific.  For a gas 
chromatographic method, specificity refers to the ability to completely separate, or 
resolve, several compounds. Selectivity can be illustrated through baseline resolution of 
components. Resolution may be calculated using Equation 2.1. 
                                                     
  
! 
R =  
t' rb - t' ra( )
1
2
Wba + Wbb( )
 (2.1) 
From Equation 2.1, R stands for resolution, t’r represents adjusted retention time, and Wb 
represents width at base of peak.  To determine the adjusted retention time (t’r), the 
retention time for the unretained compound (tm) is subtracted from the actual retention 
time (tr) from both compounds “a” and “b” (Levine, 2006).  A chromatogram further 
delineating these variables is shown in Figure 4. 
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Figure 4.  Example Chromatogram (Levine, 2006, Chapter 7, Figure 1) 
Sensitivity may be defined as the ability to detect an analyte.  In terms of 
sensitivity, the limit of detection (LOD) is the smallest analyte concentration that may be 
discerned from the noise while the limit of quantitation (LOQ) is the lowest analyte 
concentration that may be accurately measured (Skoog et al., 2007).  
The addition of salt to samples has been demonstrated to improve the sensitivity 
when detecting certain analytes by increasing the partitioning of the analyte into the 
headspace.  This process is known as the “salting out effect” (Chang, 2000).   In order to 
increase the analyte concentration in the headspace, the partition coefficient must be 
reduced.  The partition coefficient relates the “solubility of the analyte in the matrix” 
(Kolb & Ettre, 2006).  The partition coefficient is inversely proportional to the vapor 
pressure and the activity coefficient, which relates the intermolecular interaction of the 
analyte and the solvent, or matrix.  Therefore, to reduce the partition coefficient, the 
activity coefficient and/or the vapor pressure must be increased (Chang, 2000).  Vapor 
pressure increases with increasing temperature.  As for the activity coefficient, the 
addition of salt changes the sample matrix by forming a bond between the salt and the 
solvent, thereby decreasing the bond strength that previously existed between the analyte 
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and the solvent and thus allowing a volatile analyte to enter the headspace (Kolb & Ettre, 
2006). 
The degree to which a salt increases the partitioning of an analyte into the 
headspace depends not only on the analyte and the sample matrix, but also the salt itself.  
Salts are made up of positively-charged cations and negatively-charged anions that 
interact with the solvent.  Salts containing either monovalent or divalent anions may be 
used (Kalra, Tugcu, Cramer, & Garde, 2001). 
The stability of samples in a specific matrix (e.g. blood) must be tested as part of 
a method validation.  Over time, chemical degradation may occur, and temperature may 
play a role in how quickly degradation occurs (Levine, 2006).  Reproducibility takes into 
account the precision and accuracy of the method after use of the method over time 
(interday) and by different analysts (interindividual). 
 Method validation is required for forensic laboratories accredited through the 
American Society of Crime Laboratory Directors-Laboratory Accreditation Board 
(ASCLD-LAB).  ASCLD-LAB is one of the main national accrediting bodies for forensic 
testing laboratories.  According to their website, ASCLD-LAB is “dedicated to providing 
excellence in forensic science through leadership and innovation” (American Society of 
Crime Laboratory Directors, 2009).  ASCLD-LAB adheres to the standards for testing 
and calibration laboratories prepared by the International Organization for 
Standardization/International Electrotechnical Commission (ISO/IEC).   In accordance 
with the ISO/IEC standards, until an on-site method has been validated, laboratories must 




II. C. Headspace Gas Chromatography/Flame Ionization Detection 
Volatility is a measure of how quickly a substance changes from a liquid to a gas 
and highly volatile substances tend to evaporate quickly.  Because acetone is volatile, 
determining the acetone concentration in biological samples can be difficult.  Gas 
chromatography is an analytical method used for separating volatile and semivolatile 
substances in a mixture in order to identify and quantitate the substances (Skoog et al., 
2007).    
Gas chromatography works well with these substances since the separation of the 
volatile mixture is mediated by a carrier gas flowing past a stationary phase that will 
interact with the mixture components based on solubility.  Chromatographic separation of 
mixture components relies on the partitioning of the components between the stationary 
and mobile phases.  For gas chromatography, the stationary phase is the column coating 
while the mobile phase is a gas, often called a carrier gas.  After sample injection into the 
injection port of the GC, the sample is vaporized and the carrier gas then pushes the 
sample components through the column to the detector.  Sample components with a 
higher affinity for the stationary phase (i.e. components of a similar polarity to the 
stationary phase) will remain on the column longer.  The time required for a component 
to elute off the column, also known as retention time, is used to identify the component. 
A simplified scheme illustrating how gas chromatography works is given in Figure 5. 
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Figure 5.  Schematic Diagram of Gas Chromatograph (Buchinger, 2006) 
As a volatile chemical, acetone obeys Henry’s law, which states that at a given 
temperature there is a direct relationship between the amount of a volatile in a liquid and 
the amount of the volatile in the vapor above the solution (see Figure 6).   
 
Figure 6. Depiction of Henry’s Law (Koplow, 2006) 
Equipping a gas chromatograph with a headspace analyzer will allow the analysis of 
acetone and other volatile materials in the blood with little to no sample processing.  The 
headspace is the area between the liquid level and the top of the vial, and it will contain 
volatile substances that are in equilibrium with the blood.  The headspace injector is 
designed to remove these volatiles from the headspace and place them onto a 
chromatographic column for analysis.  First, the acetone is allowed to equilibrate between 
the headspace and the blood, sometimes with heating, which drives more acetone into the 
headspace. During this time, a carrier gas (usually helium or hydrogen) is used to flush 
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the injector loop.  Next the vial septum is punctured and pressurization completed.  
Carrier gas flow is then halted so the headspace vapors may fill the sample loop.   
Finally, the sample enters the column via flushing by carrier gas (Levine, 2006).   
Since acetone mainly consists of carbon, an appropriate detector would be the 
FID because it is known as a “carbon counter”.  This detector relies on the combustion or 
oxidation of carbon by a flame to signal its presence.  Burning hydrogen and air produces 
the flame, and the analyte containing carbon becomes ionized as it is burned.  There is a 
circuit set up near the flame such that without ions present in the flame, there is very little 
current flow.  In this way, as carbon-containing analytes go by and are ionized, the 
current in the circuit will increase and this signal is recorded by a computer or chart 
recorder.  The record of the signal versus time is called a chromatogram and the peaks 
will indicate when carbon compounds came out on the GC (Skoog, Holler, & Crouch, 
2007).  Flame ionization detectors are highly sensitive with a wide dynamic range.  The 
negative aspect of using the FID is that it is a sample destructive detector (Levine, 2006).  
The schematic diagram of an FID is shown in Figure 7. 
 
Figure 7. Diagram of Flame Ionization Detector (Linde Group, 2008) 
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Many articles have been published in the last twenty years detailing the use of 
HS-GC/FID for volatile chemical analysis (Barua et al., 2008; Zuba, Parczewski, & 
Reichenbacher, 2002; Streete, Ruprah, Ramsey, & Flanagan,1992).  Moreover, HS-
GC/FID has been used by other forensic laboratories in the United States for the 
quantitation of acetone in biological samples.  The Utah Public Health Laboratories 
Bureau of Forensic Toxicology analyzes acetone as part of a volatile compound 
quantitation method mainly established for the analysis of ethanol (2008).  The internal 
standard is 0.0001% (v/v) n-propanol in water, the sample size is 2 mL for either blood or 
urine, and samples are stored between 0 and 8 ºC prior to analysis.  The limits of 
detection, quantitation, and linearity for this method are 2.0 mg/dL, 5.0 mg/dL, and 15.8 
g/dL, respectively.  At the Virginia Department of Forensic Sciences, HS-GC/FID is used 
to analyze ethanol and other volatiles, including acetone (2009).  n-Propanol is used as 
the internal standard at a concentration of 0.03% (v/v) in water and at a volume of 0.45 
mL.  Sample volume for analysis is 0.05 mL blood.   
Morris-Kukoski, Jagerdeo, Schaff, and LeBeau describe a volatile chemical 
quantitation method using a dual rail robotic autosampler (2007).  For this method, one 
rail prepares samples while the other acts as the autosampler.  The authors proposed the 
use of robotics as a way to streamline volatile analysis in forensic laboratories by 
reducing manual preparations.   The limit of detection for this method is 5 mg/dL while 
the limit of quantitation is 17 mg/dL.  However, this method considers acetone an 
interferent of ethanol analysis rather than an analyte of interest.  
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II. D. Analysis in blood 
The body uses blood to transport drugs during their journey through the body.  
Testing for drugs in blood allows an analyst "to relate drug concentrations to 
pharmacological effects" (Levine, 2006).  In other words, drug concentrations in the 
bloodstream may be used to interpret the degree of intoxication, either at the time the 
blood was drawn in nonfatal cases or at the time of death for fatal cases.  Intoxication 
occurs when the level of drug exceeds either the normal level or the individual’s 
tolerance, causing behavioral and/or physical impairment.  Since acetone is highly water 
soluble, postmortem redistribution is possible from the liver to other areas of high water 
content, leading to high acetone concentrations in those areas (United States Public 
Health Service, 1994). 
Over time, blood samples may become clotted or coagulated.  Prior to sample 
preparation, clotted blood samples should be homogenized (Levine, 2006).  Whenever 
testing blood samples there is a risk of exposure to disease such as HIV or Hepatitis B, 
and all samples should be treated as biohazards.  In order to reduce the probability of 
exposure to blood-borne pathogens, the analyst should wear personal protective 






   
III. A. Headspace Gas Chromatography/Flame Ionization Detection 
This work was carried out on a Perkin Elmer Clarus 500 Gas Chromatograph 
fitted with a flame ionization detector and a Perkin Elmer Turbomatrix 110 Automated 
Headspace Sampling Unit (Figure 8) (Perkin Elmer, Inc., Waltham, MA).  High purity 
helium was the carrier gas while hydrogen was the fuel source for the detector. Helium 
was stored in a cylinder and introduced to the Gas Chromatograph via an inlet attached to 
the column head.  Hydrogen was transferred to the FID from a Parker Balston H2-90 
hydrogen generator (Parker Hannifin Corporation, Cleveland, OH). 
 
Figure 8.  Perkin Elmer Clarus 500 GC with Turbomatrix Headspace Autosampler 
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III. A. i. Instrument conditions 
Two columns, Restek Rtx-BAC1 (referred to as Channel A) and Rtx-BAC2 
(Channel B), were used for the acetone-quantitation method (Restek Chromatography 
Products, Bellefonte, PA).  According to Restek Corporation, “a dual-column 
configuration provides screening and confirmational data from the same injection” 
(1999).  Both columns were fused silica wall-coated open tubular columns, 30 m in 
length, with an inner diameter of 0.32 mm, and a film thickness of 1.20 !m.  The HS-
GC/FID conditions were as follows (Oregon State Police Forensic Sciences Division, 
2008): 
• Headspace Conditions 
o Vial Oven Temperature: 70 °C 
o Needle Temperature:  100 °C 
o Transfer Line Temperature: 100 °C 
o Injection Time:  0.02 min 
o Pressurization Time:  1.0 min 
o Withdrawal Time:  0.2 min 
o Thermostating Time:  15.2 min 
• GC Conditions 
o GC Cycle Time:  3.8 min 
o Oven Tempearture:  48 °C 
o Column Pressure:  20 psi 
o Carrier Gas Flow Rate:  20.0 mL/min 
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• FID Conditions 
o Detector Temperature: 220 °C 
o Gas Flow Rate:       H2   : 45mL/min 
   Air  : 450mL/min 
 
III. A. ii. Techniques 
 
III. A. ii. a. Sample preparation 
Sample preparation was performed using a Hamilton ML 530 B AutoPipettor 
(Hamilton Company USA, Reno, NV) consisting of two syringes and two corresponding 
pipettes: one for internal standard and one for sample.  The AutoPippettor was 
programmed to dispense 250 µL sample and 1500 µL internal-standard solution into 20 
mL headspace vials. 
When blood samples were clotted, it was necessary to manually pipette (using a 
positive-displacement pipettor) the samples into the headspace vials.   After pipetting was 
complete, a rubber septum and a metal cap were then placed on the headspace-sample 
vial, the cap was crimped, and the sample was vortexed for roughly 10 seconds.  
 
III. A. ii. b. Instrument operation 
 TurboMatrix Version 2.5.0.0125 was the software used to operate the headspace 
autosampler while TotalChrom (TC) Navigator Version 6.3.1 operated the GC (Perkin 
Elmer, Inc., Waltham, MA).  The software was configured to automatically produce a 
five-point calibration curve based on the run sequence entered.  The curve was generated 
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after manual verification of proper peak integration by the software for the samples and 
standards in each run. 
 
III. B. Experiments 
 The blood-alcohol method in place at the Portland Metropolitan Laboratory 
served as a basis for determining where to start with the method development in terms of 
chromatography conditions, sample size and internal-standard concentration.  
 
III. B. i. Development of standards and controls 
 Acetone standards from two different providers, Fisher Scientific (Thermo Fisher 
Scientific, Inc., Pittsburgh, PA) and Sigma-Aldrich (Sigma-Aldrich Co., St. Louis, MO), 
were prepared at five concentrations: 1.0, 10.0, 50.0, 100.0, and 250.0 mg/dL. Three 
controls from each provider were also prepared at a low, medium, and high 
concentration: 3.0, 25.0, and 70.0 mg/dL.  A certified reference from Cerilliant 
containing acetone at a concentration of 51.0 ± 0.21 mg/dL was included in several runs 
to demonstrate quantitative reliability in the method (Cerilliant Co., Round Rock, TX).  A 
0.25 mL aliquot of each standard and control from both providers was transferred in 
duplicate to a headspace vial.  Data from the standards prepared from either provider 
were used to create calibration curves in order to determine control concentrations.  
 
III. B. ii. Salting out effects 
 Several different salts were added to acetone samples at a constant concentration 
to see which salt, if any, increased sensitivity.  Fifty milligrams of the following seven 
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salts was added to 0.25 mL of the 70.0 mg/dL acetone control from Fisher Scientific: 
sodium sulfate (Na2SO4), sodium acetate (NaCH3CO2), sodium fluoride (NaF), sodium 
chloride (NaCl), potassium chloride (KCl), magnesium chloride (MgCl2), and calcium 
chloride (CaCl2).   The vials were capped immediately after adding the salt and were then 
vortexed for three seconds to dissolve the salt in the solution.  The samples were run in 
triplicate and the standards were run in duplicate.  Triplicate mixings of the 70.0 mg/dL 
acetone control not containing any salt were also included in the run.   
 To determine the optimal amount of salt, the following amounts of MgCl2 were 
added to 0.25 mL of the 70.0 mg/dL acetone control from Fisher Scientic: 0.05, 0.10, 
0.15, and 0.20 g.  Samples and standards were run in duplicate.  The batch also included 
duplicate mixings of a 70.0 mg/dL control without any salt.   
 
III. B. iii. Internal standard concentration 
 Internal-standard solutions with 0.05, 0.04, and 0.03% (v/v) n-propanol in water 
were prepared.   Three different sets of Fisher standards (one for each internal-standard 
concentration) were prepared and run in duplicate.  The volume of internal standard was 
maintained at 1.5 mL. 
 
III. B. iv. Sample size 
 For the blood-alcohol procedure, the Portland Lab uses a 0.25 mL sample size. 
The 0.25 mL sample size was compared to sample sizes of 0.50 mL and 0.75 mL.  Fisher 
standards at each volume were prepared in duplicate.  Fisher standards were also 
prepared in duplicate starting at a sample volume of 0.25 mL and decreasing by 0.05 mL 
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increments down to 0.05 mL.  Duplicates of the 1.0 mg/dL control at each volume were 
also included in the run. 
 
III. B. v. Limit of detection 
 For the limit of detection experiment, 12 water samples were spiked with internal 
standard solution and were subsequently run.  The ratio of acetone to internal standard 
from each blank was determined and used to calculate the “acetone concentration” for 
each blank from the calibration curve.  The mean and standard deviation were 
subsequently used to calculate the limit of detection.  
 
III. B. vi. Linear dynamic range 
 In order to demonstrate linearity, acetone samples were prepared in duplicate and 
the data was used to create a calibration curve.  Samples at the following Fisher-acetone 
concentrations were prepared: 0.01, 0.10, 1.0, 3.0, 10.0, 25.0, 70.0, 100.0, and  
250.0 mg/dL.  
 
III. B. vii. Carryover 
 In order to test the acetone method for carryover effects, five blank-blood samples 
were spiked with an extremely high acetone concentration (2500 mg/dL) and were run 
opposite five blank-blood samples.  Blank blood was purchased from the Springfield 
Forensic Laboratory (Springfield, OR).  Endogenous acetone was likely to be present in 
the blank blood, so a blank sample was run first, then a spiked sample, followed by a 
blank, then a spiked sample, and so on.   
 26 
III. B. vii. a. Carryover statistical analysis 
All statistical analyses were executed using GraphPad Prism Version 5.0 
(GraphPad Software, San Diego, CA).  At a threshold p-value, p < 0.05, the two 
measures being compared were found to be statistically different.  One-way analysis of 
variance (ANOVA) was performed on the carryover data, followed by Tukey’s multiple 
comparison posttest to establish whether or not the calculated acetone concentrations in 
the blank blood samples were statistically different. 
 
III. B. viii. Stability study 
 To test the stability of samples containing acetone, three different case samples 
were tested several times over a two-month period.  The following case samples were 
analyzed: 08M-1173, 08M-1179, and 08M-1182.  The samples were first tested on 
January 23, 2009, hereafter referred to as time 0 days.  Samples from each case were then 
stored at room temperature (23 ºC), in the refrigerator (4 ºC), and in the freezer (-11 ºC). 
The samples were tested again after 7, 28, and 56 days.    
 
III. B. viii. a. Stability study statistical analysis 
 Two-way ANOVA was performed in order to compare the effect of both 
temperature and time on the stability of acetone-containing samples.  After performing 
ANOVA, Bonferroni post tests were run to compare storage temperatures (i.e. freezer vs. 
refrigerator) as well as storage time (i.e. t=0 days vs. t=56 days) for each case. 
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III. B. ix. Method validation 
 To validate the method, three control concentrations were tested numerous times.  
The controls were made using Fisher acetone at the following concentrations: 3.0, 25.0, 
75.0 mg/dL.  Twelve runs were completed, each containing the following samples: the 
five standards, a negative sample, a certifiable control, and 33 of each the low, medium, 
and high controls.  In order to test for interday and interindividual variations, two 
different analysts performed the runs (Susan L. Talbert and Michael D. Jackson) on 
separate days.  
 With the method developed, post-mortem case samples known to contain acetone 
were tested as part of the method validation.  The following case samples were analyzed: 
08M-256, 08M-271, 08M-587 08M-652, 08M-737, 08M-880, and 08M-903.  The 
standards were run in singlet followed by the low, medium, and high controls, a 
certifiable Cerilliant control, a blank, a low control, the case samples in duplicate, and a 
medium control.  The calculated acetone concentrations were compared to results from 
the external laboratory.   
 
III. B. ix. a.  Method validation statistical analysis 
 To calculate the interday variation, data for each control from all days (but 
excluding data from batches ran by Michael D. Jackson) was pooled.  Column statistics 
were performed to determine the mean and standard deviation over all days.  The percent 
variation for each control was then calculated using Equation 3.1. 
   
  !!
! 
percent variation =  
standard deviation
mean
""##                           (3.1) 
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Percent variations from each control were averaged and reported as the final interday 
variation.   
 For the interindividual variation, the data for each control from both analysts was 
pooled and column statistics were performed to determine the mean and standard 
deviation at each control concentration.  For each control, the percent variation was 
calculated then the average percent variation over all controls was determined.  Since the 
analyses were performed on different days, the final interindividual variation was 
calculated by subtracting the interday variation from the averaged percent variation. 
  







IV. A. Selectivity 
Selectivity was demonstrated using the compounds contained in the certifiable 
reference from Cerilliant.  The elution profile from the Cerilliant volatile mixture is 
shown in Figure 9 while the calculated resolutions are given in Table 1. 
 
Figure 9.  Elution profile from Cerilliant Volatile Mixture.  The 
volatile mixture contained methanol, ethanol, isopropanol, and acetone at 
concentrations of 50.74 ± 0.39, 50.42 ± 0.31, 50.43 ± 0.16, and 51.04 ± 
0.21 mg/dL, respectively.  The internal standard, n-propanol, was included 
at 0.05% (v/v) in water.  
 
Table 1.  Component Resolution from Cerilliant Volatile Mixture  






Acetone -  
n-Propanol 




IV. B. Development of standards and controls 
Acetone standards from both Fisher Scientific and Sigma-Aldrich were run on 
both the Rtx BAC-1 and BAC-2 columns (Channels A and B, respectively).   After the 
data was processed, the acetone concentration was plotted versus the ratio of acetone 
peak area to n-propanol peak area to create calibration curves.  Correlation coefficients 
for curves from both providers as well as both Channels were at or above 0.9998.  
Calibration curves from Channel A for Fisher Scientific and Sigma-Aldrich were 
combined and are shown in Figure 10.   
 
Figure 10. Standard Calibration Curve (n=2).  The acetone/n-propanol 
peak area ratio was plotted versus the acetone concentration and the best-
fit line yielded a correlation coefficient of 0.9999. 
 
The best-fit line equation from Figure 7 was used to calculate acetone control 
concentrations from Fisher as well as a certifiable control from Cerilliant, as shown in 
Table 2. 
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Table 2. Acetone Control Concentrations (n=2) 
Sample Name Average Acetone/n-
propanol Area Ratio 




3.0 Control 0.025 3.51 15.8 
25.0 Control 0.205 24.0 4.06 
70.0 Control 0.573 65.9 6.10 
51.0 Cerilliant 
Control 
0.408 47.1 8.04 
 
IV. C. Salting out effects 
 The effect of each salt on the analyte/internal standard peak area ratio, 
subsequently used to determine the acetone concentration, is shown in Figure 11. 
 
Figure 11.  Effect of Salt on Calculated Acetone Control Concentration 
(n=3).  For the salt study, 0.05 g of each salt was added to 0.25 mL of the 
70 mg/dL acetone control from Fisher Scientific. 
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 The addition of each of the salts slightly decreased the detector response (Figure 
11).  Lower ratios of acetone peak area to n-propanol peak area led to an apparent 
decrease in calculated acetone concentrations as shown in Table 3. 
Table 3. Effect of Salt on Calculated Acetone Control Concentration (n=3) 
Sample Name Average Acetone/n-
propanol Area Ratio 




70 mg/dL Control 
 
0.554 68.3 2.50 
70 mg/dL Control + 
0.05 g Na2SO4 
0.540 66.6 5.02 
70 mg/dL Control + 
0.05 g NaCH3CO2 
0.549 67.7 3.40 
70 mg/dL Control + 
0.05 g NaF 
0.536 66.1 5.70 
70 mg/dL Control + 
0.05 g NaCl 
0.532 65.8 6.13 
70 mg/dL Control + 
0.05 g KCl 
0.533 65.7 6.28 
70 mg/dL Control + 
0.05 g MgCl2 
0.547 67.4 3.81 
70 mg/dL Control + 
0.05 g CaCl2 
0.537 66.3 5.50 
 
Magnesium chloride was chosen at random to demonstrate the effect that varying 
the amount of salt has on calculated acetone concentrations, as shown in Figure 12.  
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Figure 12.  Effect of MgCl2 on Calculated Acetone Control 
Concentration (n=2).  A range of MgCl2 from 0.05 to 0.20 g was added 
to 0.25 mL of the 70 mg/dL acetone control from Fisher Scientific. 
 





Average Calculated Acetone 
Concentration (mg/dL) 






70.0 mg/dL Control + 







70.0 mg/dL Control + 







70.0 mg/dL Control + 





70.0 mg/dL Control + 





As demonstrated in Figure 12, an increased salt amount resulted in an apparent 
decreased calculated acetone concentration.  Table 4 shows that as the salt amount 
increased, so did the n-propanol area, though the acetone peak area remained relatively 
constant.  
 34 
IV. D. Internal standard concentration 
 Internal-standard solutions were prepared at 0.05, 0.04, and 0.03% (v/v) n-
propanol in water.  Figures 13a and 13b show chromatograms at the same concentration 
for the greatest and least concentrated internal standard solutions, respectively. 
 
 
Figure 13a.  Chromatogram 50 mg/dL Acetone Standard with 0.05% 
(v/v) Internal Standard.  The chromatogram illustrates the relationship 
between the acetone and n-propanol peaks for the midrange calibrator at 





Figure 13b. Chromatogram 50 mg/dL Acetone Standard with 0.03% 
(v/v) Internal Standard. The chromatogram shows the relationship 
between the acetone and n-propanol peaks for the midrange calibrator at a 
decreased internal standard concentration, 0.03% n-propanol in water. 
 
 In Figures 13a and 13b, the peaks with retention times around 1.67 minutes 
represent acetone while the peaks with retention times around 1.81 minutes represent n-
propanol.  The peak for the internal standard in Figure 13a has a height roughly 100 units 
higher than the internal standard peak in Figure 13b.  The acetone peak has a height 
around 130 units in either figure.  
Three separate calibration curves were created, one for each internal standard 
concentration.  The acetone concentrations were calculated from the corresponding 
calibration curve best-fit line and are shown in Table 5. 
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with 0.05% IS 
192264 474703 0.405 49.5 
50.0 Calibrator 
with 0.04% IS 
193664 375798 0.515 49.2 
50.0 Calibrator 
with 0.03% IS 
193987 274084 0.708 49.4 
 
 
IV. E. Sample size 
 The effect of sample size on accuracy of the method was assessed.  Volumes of 
0.75, 0.50, 0.20, 0.25, 0.15, 0.10, and 0.05 mL containing the standard concentrations of 
acetone (i.e. 1.0, 10.0, 50.0, 100.0, and 250.0 mg/dL) were included in the assay.  Figure 
14 demonstrates the effect of a large sample size on the chromatogram, when the detector 
has been saturated. 
 
Figure 14. Chromatogram 250 mg/dL Acetone, 0.75 mL Sample.  The 
chromatogram shows the effect of detector saturation as a result of an 
increased sample size. 
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Table 6 illustrates the effect of sample size on the acetone/n-propanol peak area 
ratio.    
Table 6. Effect of Sample Size on Peak Area Ratio 







0.20  2.96 
0.15  2.59 
0.10  2.10 
0.05  0.66 
 
 Table 6 demonstrates that, for the most part, as sample size increases so does the 
analyte/internal standard peak area ratio since the internal standard amounts stays 
constant.  Linearity of data may also be considered when determining an appropriate 
sample size.  Separate calibration curves were created for each sample volume using 
standards run in duplicate.  The effect of sample size on the correlation coefficient from 
the corresponding calibration curve is shown in Table 7. 
Table 7.  Effect of Sample Size on Acetone Calibration Curve Data 
Sample Volume (mL) Correlation Coefficient 
0.75  0.9956 
0.50  0.9997 
0.25   0.9999 
0.20   0.9981 
0.15   0.9995 
0.10   0.9991 
0.05   0.9986 
 
From Table 7, there is no apparent trend in correlation coefficients as compared to 




IV. F. Limit of detection 
 Twelve blank water samples were injected with 1.5 mL of 0.05% (v/v) n-propanol 
in water internal standard solution.  The data and results are presented in Table 8. 
Table 8.  Limit of Detection Calculations for Blank Water Samples (n=12) 








585.8 474140 0.0012 0.117 
556.9 493140 0.0011 0.104 
660.3 474679 0.0014 0.137 
475.7 460317 0.0010 0.092 
367.2 449946 0.0008 0.064 
751.4 475402 0.0016 0.161 
856.0 461833 0.0019 0.195 
339.8 491240 0.0007 0.049 
209.5 512111 0.0004 0.013 
629.3 491531 0.0013 0.123 
1038.4 489477 0.0021 0.229 
1031.3 478854 0.0022 0.233 
Mean (mg/dL) 0.126 
Std. Dev. (mg/dL) 0.069 
 
   
From Table 8, the mean acetone concentration and the average standard deviation of the 
blank samples were calculated to be 0.126 ± 0.069 mg/dL.  The limit of detection was 
calculated using the equation LOD = X + 3"SD where LOD stands for limit of detection, 
X for mean concentration of the blanks, and SD for standard deviation of the blanks.  
From this equation, the limit of detection was determined to be 0.333 mg/dL.  In a similar 
fashion, the limit of quantitation was calculated using the equation LOQ = X + 10"SD, 
yielding a value of 0.816 mg/dL. 
 
IV. G. Linear dynamic range 
 The linear dynamic range can be determined by calculating the limits of 
quantitation and linearity.  The theoretical limit of quantitation was previously calculated 
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as 0.816 mg/dL.  No experimentation was performed to calculate the limit of linearity.  
However, an administrative linear dynamic range can be established by taking into 
consideration known normal and toxic blood-acetone concentrations (1 and 33 mg/dL, 
respectively), acetone levels for persons experiencing ketoacidosis (10-70 mg/dL), and 
the determined acetone concentrations from previously analyzed cases (generally less 
than 30 mg/dL, one case at 230 mg/dL).  For methods created with several target 
analytes, the normal and toxic concentrations of each analyte must be considered before 
an administrative linear dynamic range can be set.  Figure 15 shows a calibration curve 
established using an administrative linear dynamic range up to 250.0 mg/dL.  The 
corresponding data is given in Table 9. 
 
Figure 15.  Linear Dynamic Range Curve (n=2). The acetone/n-
propanol peak area ratio was plotted versus the acetone concentration and 




Table 9.  Linear Dynamic Range Data (n=2) 
Sample Average Calculated Acetone 
Concentration (mg/dL) 
Percent Error 
0.01 Calibrator ND (not detected) ND 
0.10 Calibrator 0.201 101 
1.0 Calibrator 0.950 5.02 
3.0 Calibrator 2.96 1.27 
10.0 Calibrator 11.7 17.3 
25.0 Calibrator 25.3 1.20 
70.0 Calibrator 67.3 3.80 
100.0 Calibrator 99.5 0.467 
250.0 Calibrator 251 0.321 
 
 
IV. H. Carryover 
 Data and results from the carryover study are presented in Table 10. 













In Table 10, the spiked samples severely saturated the detector, making acetone-
concentration calculations impossible.  The calculated acetone concentration of the blank 
samples had a mean value of 1.01 ± 0.01 mg/dL.   
 
 
IV. I. Stability study 
Prior to starting the stability studies, all samples had been stored in the 
refrigerator.  Results from the first analysis are provided in Table 11. 
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Table 11.  Stability Study Data Time = 0 days 






1179 24.15 0.596 2.47 
1173 11.85 0.040 0.34 
1182 44.33 0.685 1.54 
 
 The external laboratory reported the following acetone concentrations for cases 
1179, 1173, and 1182, respectively: 23, 12, and 36 mg/dL.  An unpaired t-test between 
the external laboratory reported concentrations versus concentrations calculated in this 
assay was performed using GraphPad Prism software, and the concentrations were not 
found to be statistically different. 
After the initial analysis, separate 3 mL aliquots of each sample were stored at 
room temperature (23 °C), in the refrigerator (4 °C), and in the freezer (-11 °C). The 
samples were analyzed again after 7, 28, and 56 days.  Results are summarized in Tables 
12 through 14, where average calculated acetone concentration (mg/dL) was abbreviated 
as Conc, standard deviation as SD, and percent relative standard deviation as RSD.  
Table 12.  Stability Study Data Time = 7 days 
 Case #1179 Case #1173 Case #1182 
Storage Location Conc SD RSD Conc SD RSD Conc SD RSD 
Freezer 25.56 1.08 4.24 12.17 0.022 0.177 42.31 0.785 1.86 
Refrigerator 25.20 1.37 5.44 12.25 0.371 3.03 41.77 0.128 0.307 
Room Temperature 25.10 1.04 4.16 10.56 2.05 25.1 43.55 0.676 1.55 
 
Table 13.  Stability Study Data Time = 28 days 
 Case #1179 Case #1173 Case #1182 
Storage Location Conc SD RSD Conc SD RSD Conc SD RSD 
Freezer 26.35 0.496 1.88 13.23 0.454 3.43 42.88 0.933 2.18 
Refrigerator 24.90 0.533 2.14 12.00 0.878 7.32 45.35 0.902 1.99 
Room Temperature 26.05 0.801 3.08 9.55 0.015 0.160 43.72 1.14 2.61 
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Table 14.  Stability Study Data Time = 56 days 
 Case #1179 Case #1173 Case #1182 
Storage Location Conc SD RSD Conc SD RSD Conc SD RSD 
Freezer 26.56 1.01 3.82 12.85 0.259 2.01 43.31 2.20 4.76 
Refrigerator 25.47 0.886 3.48 13.21 0.587 4.45 44.38 0.843 1.90 
Room Temperature 31.05 0.788 2.54 5.68 0.727 12.8 35.52 3.95 11.1 
 
 Data from Tables 11 through 14 were analyzed using GraphPad Prism software.  
From two-way ANOVA, temperature was found to account for 0.22% of the variation 
and time was found to account for 97.7% of the variation, though the relative standard 
deviation was quite small.  
 
IV. J. Method validation 
 For the method validation, interday and interindividual variation was calculated. 
Table 15 presents the statistical results from the validation study. 
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In Table 15, Michael D. Jackson ran the following batches: 20090107, 20090108, 
20090121, 20090305, 20090317, and 20090319.  Susan L. Talbert ran the remaining 
batches.  Results from batches ran by Susan L. Talbert were pooled for each control 
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concentration.  Percent variation for each control was then calculated by dividing the 
standard deviation by the mean and multiplying by 100.  The resultant percent variations 
were averaged to determine the interday variation.  The final percent interday variation, 
or variation between days, was calculated as 6.93 percent.   
Separate statistics for each experimenter were performed on the calculated 
acetone-control concentrations and the results are summarized in Table 16.  
Table 16.  Statistics for Interindividual Variation from Validation Study 
Mean Concentration ± Standard Deviation (mg/dL) Control Concentration 
(mg/dL) Michael D. Jackson Susan L. Talbert Pooled 
3.0 3.27 ± 0.79 3.81 ± 0.74 3.51 ± 0.74 
25.0 24.7 ± 0.33 25.1 ± 0.66 24.9 ± 0.54 
75.0 74.7 ± 0.45 76.5 ± 3.4 75.1 ± 1.79 
 
The pooled mean concentrations and standard deviations in Table 16 were used to 
determine the corresponding percent variation for each control.  Since the analyses were 
performed on separate days, the interday variation from either user was averaged, and 
then subtracted from this pooled interday and interindividual variation calculation, 
yielding an interindividual percent variation of 0.77%. 
 Post-mortem case samples known to contain acetone were also tested as part of 
the method validation.  The following case samples were analyzed: 08M-256, 08M-271, 
08M-587 08M-652, 08M-737, 08M-880, and 08M-903.  Results are provided in  
Table 17. 
 44 
Table 17.  Postmortem Sample Analysis (n=2) 
Case # External Laboratory Reported 
Acetone Concentration (mg/dL) 
Avg. Calculated Acetone Concentration 
< Standard Deviation (mg/dL) 
903 37 54.7 8&+*,3 
880 6.8 8.31 8&+*+5 
652 3.6 2.78 8&+*+4 
737 230 400 8&+*-7 
256 12 14.3 8&+*+5 
587 0 0 8&+*+' 
271 5.6 4.92 8&'*4 
 
For case 587, a calculated acetone concentration of 0.0099 mg/dL was obtained.  Since 
the linear dynamic range has an administrative limit of quantitation at 1.0 mg/dL, the 
value was reported as 0 mg/dL.   An unpaired t-test was performed using GraphPad Prism 
software between the external laboratory’s reported acetone concentration and those 








V. A. Method development 
In terms of gas chromatography, resolution may be defined as the complete 
separation of components as demonstrated by the chromatogram.  Resolution may be 
calculated using the retention times of the compounds as well as the width of the peak for 
each compound, as displayed in equation 2.1.  A calculated resolution at or above 1.5 
indicates that the compounds have been completely resolved while a resolution at 1.0 
signifies a 10% overlap between peaks “a” and “b” (Levine, 2006).  From Table 1, all 
compounds were shown to be fully separate from the closest neighboring compound, 
thereby proving this method to be selective. 
Standard concentrations were selected based on previous case samples reviewed 
by the Portland lab.  The concentrations of the controls were between the lowest and 
highest concentrations of the standards, but were not equivalent to any of the standard 
concentrations. From Figure 10, the calibrators from both Fisher Scientific and Sigma-
Aldrich were statistically similar.  Therefore, only standards and controls prepared using 
acetone from Fisher Scientific were used in subsequent experiments.  The use of two 
columns served as a confirmatory tool in terms of identification via retention time.  
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Channel B was the confirmatory column, so only data from Channel A was analyzed in 
the remaining experiments.   
The use of peak height as compared to peak area for developing the ratio of 
acetone to n-propanol was investigated.  Levine states that the use of peak height ratios is 
only necessary “for the quantitation of a small peak in the presence of a larger, closely 
eluting peak” (2006).  As demonstrated by the calculated resolution presented in Table 1, 
acetone and n-propanol were not shown to overlap but were cleanly separated using this 
method.  Moreover, no significant difference in accuracy of calculated acetone 
concentration was noted and peak area ratios were used throughout the entire study.   
Accuracy of the calculated control concentrations was demonstrated via percent 
error calculations.  Table 2 shows that the percent error between the calculated acetone 
concentration and the expected concentration was less than 20% for all controls.  This 
value is a general measure of quality control for quantitation in the field of forensic 
science (Levine, 2006). 
Volatile chemicals often have a high vapor pressure, meaning that while they 
exist as a liquid at room temperature they evaporate rapidly in the open air and will form 
a concentrated headspace in a sealed container.  The addition of salts to volatile chemical 
solutions has been found to increase the vapor pressure of some chemicals and thereby 
increase the sensitivity in detection during headspace analysis.  
From the salt study (section IV. C.), the addition of salt was found to be 
unnecessary for acetone-containing samples.  Salts decreased the accuracy in calculated 
acetone concentrations because they exhibited a greater effect on n-propanol than 
acetone.   According to Kolb and Ettre, polar compounds are more affected by salts than 
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nonpolar compounds (2006). Acetone and n-propanol are both polar, though acetone is 
slightly more polar than n-propanol, with polarity indices of 5.1 and 4.0, respectively.  In 
terms of the extent to which compounds of varying degrees of polarity are affected by 
salts, the authors simply state, “The effect is not the same for every analyte” (Kolb & 
Ettre, 2006).  For this study, salts appear to have a greater effect on n-propanol than on 
acetone.  The addition of salt to acetone-containing samples was deemed unnecessary, as 
it did not result in greater sensitivity in detecting acetone.   
Internal standard concentration was not found to affect calculated acetone 
concentrations.  Decreasing the internal standard concentration led to an increase in the 
ratio of analyte to internal standard.  That is, the analyte peak appeared larger than the 
internal standard peak as the internal standard concentration decreased.  An optimal 
internal standard concentration should be small enough to allow peak detection at low 
concentrations and concurrently high enough to provide a comparable internal standard 
peak intensity to the acetone peak at high concentrations.  For the 0.05 percent internal 
standard concentration, the acetone peak is clearly discernable at an acetone 
concentration of 1.0 mg/dL and is only twice as large as the n-propanol peak at an 
acetone concentration of 250.0 mg/dL.   Therefore, the internal solution concentration 
was maintained at 0.05 percent n-propanol in water.  
Sample size was increased to see if a larger volume resulted in better detection of 
acetone at low concentrations, then decreased to determine the lowest volume that still 
produced sufficient detection of low acetone levels.  Sample volume was not found to 
have a great effect on calculated acetone concentrations, indicating that as long as enough 
total acetone is present in a sample, the calculated concentrations will be accurate. 
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The truncated acetone peak in Figure 14 illustrates that, as a result of the 
increased total acetone in the larger sample, a large sample size saturates the detector.  
Furthermore, the acetone peak is more than five times the size of the internal standard 
peak.  The analyte peak should not completely overwhelm the internal standard peak, and 
therefore a smaller analyte/internal standard ratio is desirable.   
At the same time, a low sample size resulted in decreased peak areas, which made 
it difficult to detect the acetone peak at low acetone concentrations.  The acetone peak at 
1.0 mg/dL is easily detectable at a sample volume of 0.25 mL and the acetone peak does 
not overwhelm the internal standard peak at the highest acetone standard concentration, 
as seen in Table 6.  In terms of calibration curve linearity, all of the tested sample 
volumes do meet the Portland Metropolitan Forensic Laboratory’s lower correlation 
coefficient limit of 0.99.  However, the calibration curve created using standards with a 
sample volume of 0.25 mL had the correlation coefficient closest to 1.0.  Therefore, of 
the sample sizes considered, 0.25 mL is the optimal sample size.  Since quantitation 
samples are generally run in duplicate, only a total sample volume of 0.50 mL is required 
for this acetone quantitation method.   
The instrument’s limit of detection was calculated to be 0.333 mg/dL. The 
external laboratory reports a limit of detection for acetone of 1 mg/dL.  Though the 
instrument may detect acetone as low as 0.333 mg/dL, quantitations should not be 
reported at concentrations below the limit of quantitation.  The limit of quantitation for 
this method represents the lowest acetone concentration that can be accurately and 
precisely measured (Levine, 2006).  The limit of quantitation was calculated to be 0.816 
mg/dL.   
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Percent error calculations were performed on the calculated acetone 
concentrations in the dynamic range study. A small percent error signifies that the 
calculated acetone concentration is close to the expected acetone concentration.  Percent 
error of less than 20 percent was chosen as the acceptance criteria.  This value serves as a 
general measure in evaluating quality control for quantitation in the field of forensic 
science (Levine, 2006).  Because accuracy was not within 20 percent at acetone 
concentrations below 1mg/dL and samples are rarely presented at concentrations greater 
than 250.0 mg/dL, the linear dynamic range was administratively set from 1.0 to 250.0 
mg/dL.  If a sample has a calculated acetone concentration below 1.0 mg/dL, it should be 
reported as 0 mg/dL, or simply as negative for acetone unless sample size is modified 
such that the quantitative ratio falls between the cutoff and high calibrator.  Samples with 
acetone concentrations above 250.0 mg/dL may be extrapolated from the calibration 
curve.  However, many laboratories require that samples determined to have 
concentrations above the highest tested standard be diluted and reanalyzed. 
No carryover was found to exist between substantially spiked and blank blood 
samples.  Since the normal level of acetone in the blood is around 1 mg/dL (Ashley et al., 
1994), it can be assumed that the acetone present in the blank blood samples was 
endogenous and was not a result of carryover from the spiked samples.  Moreover, the 
samples were run in the sequence shown in Table 10.  A blank sample was run first and 
the standard deviation was only 0.007 mg/dL.  From one-way ANOVA, the mean 
concentrations from the ten blank blood samples were not found to be significantly 
different.  Tukey’s multiple comparison post-test confirmed that none of the calculated 
acetone concentrations from the blank blood samples were statistically different at 95% 
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confidence.  Furthermore, the headspace autosampler heated samples to 200 °C before 
analysis so any variability in room temperature can be negated.  
For the stability study, all samples were stored in microcentrifuge tubes.  Two 
microcentrifuge tubes were used for each case at each temperature with a total volume of 
about 3 mL.  All of the samples had some degree of coagulation, or clotting.  Therefore, 
the AutoPipettor could not be utilized when preparing samples for analysis.  Instead, the 
samples had to be manually pipetted.  In order to compare storage temperature to time for 
each case sample, two-way ANOVA of the data was performed using GraphPad Prism 
software.  Temperature was only found to account for 0.22 percent of variation (not 
significant) while time accounted for 97.7 percent variation (extremely significant).    
From Bonferroni post-tests, only case 1182 at time 56 days had mean concentrations that 
were significantly different (for both the freezer vs. room and refrigerator vs. room tests).   
Though GraphPad Prism software determined that time but not temperature plays 
a significant role in acetone concentration variation, no overall trend was apparent in the 
data.  The calculated acetone concentration increased for some cases but decreased for 
others, even at the same storage temperature.  An increase in calculated acetone 
concentrations could be due to microorganism activity.  Acetone is one of many 
metabolic byproducts produced by microorganism activity in postmortem blood samples, 
though the main product is ethanol.  Glucose, fatty acids, and amino acids may all be 
converted to acetone by microorganisms (Levine, 2006).  Numerous species of microbes 
are capable of producing volatiles, but the yeast Candida albicans has been identified as 
one of the highest contributors.  Adding a preservative to postmortem samples may 
prevent microorganism growth and thereby reduce the amount of volatiles produced 
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postmortem (Lewis, Johnson, Angier, & Vu, 2004).  The Portland Metropolitan Lab has 
attempted to decrease or prevent postmortem volatile production by adding 0.5% sodium 
fluoride to blood samples.  
A decrease in calculated acetone concentrations may be due to simple 
evaporation.  With numerous analyses, the sample in the storage container is depleted, 
and a larger space between the top of the sample and the lid is created.  Since acetone is a 
volatile chemical, it has the tendency to diffuse out of the sample into the air space.  Loss 
of acetone can subsequently occur when the storage container is opened to aliquot the 
sample for analysis.   
The calculated acetone concentration from each case at time 0 was compared to 
the reported concentrations from the external laboratory.  The concentrations were not 
found to be significantly different.  For each case, the blood collection site given on the 
sample vials at the Portland Metropolitan Forensic Laboratory was the same as that 
provided on the external laboratory case report.  Moreover, all samples (from both the 
stability study and the postmortem study) analyzed by the external lab and those present 
at the lab were stored in gray-stopper vials.  A summary of the collection information for 
the stability study blood samples is given in Table 18.   







V. B. Method validation 
From the validation experiment, interday variation was found to be 6.93% while 
interindividual variation was found to be 0.77%.  Both types of variation serve as a 
measure of precision.  Before averaging the percent variations from each control 
concentration for both variation studies, the low control at 3.0 mg/dL exhibited the 
greatest percent variation.  Therefore, precision is greater at high acetone concentrations 
than it is at low acetone concentrations.    
In order to calculate the interindividual variation, the interday variation had to be 
subtracted from a preliminary interindividual variation because the analyses were 
performed on different days.  For that reason, when two different operators perform 
analyses on different days, the variation in calculated acetone concentrations would be 
greater than if the same operator performed analyses on different days or if two operators 
performed analyses on the same day.  Though both experimenters follow the same 
general procedure for sample preparation, different people do things in a slightly different 
fashion.   A greater degree of variation should therefore be expected between individuals 
as compared to the same individual running the same experiment on different days. 
The pooled mean and standard deviation for each control from either analyst was 
compared to further evaluate accuracy and precision between individuals.  The average 
calculated means for the low and high controls from the batches ran by Michael D. 
Jackson were slightly more accurate than those ran by Susan L. Talbert.  The standard 
deviations for either operator at the low control concentration were more consistent than 
the standard deviations at the high control concentration.    
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Acetone is normally present in the blood at a concentration around 1 mg/dL 
(Ashley, 1994) while concentrations above 33 mg/dL are toxic (Burns et al., 1998).  Of 
the postmortem cases analyzed, all calculated acetone concentrations were above the 
normal level.  Only cases 903 and 737 had concentrations above the toxic level.  The 
calculated acetone concentration for case 737 was 400 mg/dL; more than ten times the 
toxic level.  
In controlled diabetics, acetone concentrations in blood are usually under  
3 mg/dL (Jones, 1993) and the calculated acetone concentration for case 652 was  
2.57 mg/dL.  People on ketogenic diets or experiencing ketoacidosis may have acetone 
blood concentrations ranging from 10 to 70 mg/dL (Baselt, 2000).  The blood sample 
from case 903, with a calculated acetone concentration of 53.7 mg/dL, could have been 
drawn from an individual on a ketogenic diet or in diabetic ketoacidosis.  The remaining 
two cases, 880 and 271, had only slightly elevated levels of acetone, which can be caused 
by diet and/or exercise. 
The acetone quantitation method developed during this study was similar to the 
method used by the external lab, which was GC/FID with n-propanol as the internal 
standard.  However, the external lab calculated acetone concentrations using a historic 
curve rather than running standards with every batch.   Historic calibration curves are 
effective as long as positive and negative control samples are included with each batch to 
ensure that the “calibration has not changed between batches” (Levine, 2006).  The 
external lab ran samples in singlet, so no mean or standard deviation data was available 
(personal communication, April 21, 2009).  This led to a decrease in statistical power 
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when performing comparisons between acetone concentrations calculated using the 
developed method and those reported by the external lab.   
Both a t-test and an F-test were performed on the postmortem sample data using 
GraphPad Prism software.  Neither the mean nor variance from the calculated acetone 
concentrations was statistically different from values reported by the external lab.  The 
calculated concentration from case 737 was 400 mg/dL.  While this value is within the 
known saturation level, it had to be extrapolated from the calibration curve.  Generally, a 
protocol exists requiring that samples beyond the range of calibration standards be diluted 
and subsequently reanalyzed.    
Samples analyzed by the external lab were drawn from the same part of the body 
as the samples analyzed using this method (except for case 737, which they reported as 
unknown).  However, the case samples were not returned after analysis at the external 
lab.  Therefore, the blood samples analyzed using the new method, while they did come 
from the same subject, may have been more or less viscous than the previously analyzed 
samples. Samples with lower viscosity contain more water, which can lead to a higher 
calculated acetone concentration since acetone is hydrophilic and is therefore distributed  
to the water portion of the blood.  Coagulation can also affect the calculated acetone 
concentration, and all of the samples were at least slightly coagulated. 
 
 V. C. Conclusion 
A precise, accurate, selective, and sensitive method for acetone quantitation in 
blood using headspace gas chromatography with flame ionization was both developed 
and validated.  Precision was determined using standard deviation, accuracy by percent 
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error, selectivity by chromatographic resolution of components, and sensitivity by the 
limits of detection and quantitation. 
 The final method used standards prepared from Fisher Scientific acetone at 
concentrations of 1.0, 10.0, 50.0, 100.0, and 250.0 mg/dL.  Positive controls were 
prepared in a similar fashion at concentrations of 3.0, 25.0, and 70.0 mg/dL.  For sample 
analysis, a 0.25 mL aliquot of blood and 1.5 mL of 0.05 percent n-propanol in water 
internal standard solution were combined in a headspace vial.  No salt was added to the 
vial.  Samples were run in duplicate and the acetone concentration was determined by 
interpolation from a calibration curve created using standards included in the same batch 
as the samples.  If the correlation coefficient of the calibration curve was at or above 0.99 
and the standard concentrations were within 20 percent of the expected value, the 
calculated acetone concentrations were assumed to be accurate.   
Though the limit of detection was 0.333 mg/dL, any calculated concentrations 
below the administrative limit of quantitation at 1.0 mg/dL were reported as negative.  
Based on the administrative limit of linearity, samples with calculated acetone 
concentrations above 250.0 mg/dL should be diluted and reanalyzed.  Carryover from 
samples of high acetone concentration to samples of lower acetone concentration was not 
observed.  The method can be used on different days and/or by different experimenters 
while expecting calculated-concentration variations of 6.93 and 8.59 percent, 
respectively.  Samples may be stored at any temperature, though the acetone 
concentration will fluctuate over time.
 56 
REFERENCES 
(2009). Rtx®-BAC1 (Fused Silica). Retrieved October 21, 2008, from Restek 
Chromatography Products Web site: http://www.restek.com/restek/prod/57.asp 
 
Amalfitano, G., Bessard, J., Vincent, F., Eysseric, H., & Bessard, G. (1996). Gas 
chromatographic quantitation of dextropropoxyphene and norpropoxypheine in 
urine after solid-phase extraction. Journal of Analytical Toxicology, 20(7), 547-
554. 
 
American Society of Crime Laboratory Directors. (2009). About ASCLD. Retrieved June 
10, 2009, from American Society of Crime Laboratory Directors Web site: 
http://www.ascld.org/content/about-ascld 
 
Ashley, D. L. (1994).  Blood concentration of volatile organic compounds in a 
nonoccupationally exposed U.S. population and in groups with suspected 
exposure.  Clinical Chemistry, 40, 1401-1404. 
 
Barua, R., Chi, L., Fitzpatrick, R., Gillard, D., & Kostyniak, P. J. (2008). Determination 
of Volatile Organic Compounds in Biological Samples Using Headspace Solid-
Phase Microextraction and Gas Chromatography: Toluene and Styrene. Journal of 
Analytical Toxicology. 32(5), 379-386. 
 
Baselt, R. C. (2000). Disposition of Toxic Drugs and Chemicals in Man (5
th
 ed.). Foster 
City, CA: Chemical Toxicology Institute. 
 
Berg, J. M., Tymoczko, J. L., & Stryer, L. (2002). Biochemistry (5
th
 ed.).  New York, 
NY: W. H. Freeman and Co. 
 
Bowen, S. E., Daniel, J., & Balster R. L.  (1999). Deaths associated with inhalant abuse 
in Virginia from 1987 to 1996.  Drug and Alcohol Dependence. 53(3), 239-245. 
 
Buchinger, S. (2006). Metabolome analysis of Corynebacterium glutamicum. Retrieved 
May 24, 2009, from Cologne University Bioinformatics Center Web site: 
http://www.cubic.uni-koeln.de/research/horstmann/metabolom.html 
 
Chang, R. (2000). Physical Chemistry for the Chemical and Biological Sciences (3
rd
 ed.).  




Deng, C., Zhang, W., Zhang, J., & Zhang, X. (2004).  Rapid determination of acetone in 
human plasma by gas chromatography-mass spectrometry and solid-phase 
microextraction with on-fiber derivatization.  Journal of Chromatography B. 
805(2), 235-240. 
 
Dietz, D. D., Leininger, J. R., Rauckman, E. J., Thompson, M. B., Chapin, R. E., 
Morrissey, R. L., & Levine, B. S. (1991).  Toxicity studies of acetone 
administered in the drinking water of rodents.  Fundamental and Applied 
Toxicology.  17(2), 347-360. 
 
Federal Bureau of Investigation. (2009). Standards for forensic DNA testing laboratories.  
Retrieved June 10, 2009, from Federal Bureau of Investigation Web site: 
http://www.fbi.gov/hq/lab/codis/forensic.htm 
 
Felby, S., Nielsen, E. (1994). Determination of ketone bodies in postmortem blood by 
head-space gas chromatography. Forensic Science International. 64(2-3), 83-88. 
 
Gluodenis, T. (2007). Blood. sweat, and tears -- GC/MS in forensic toxicology. Retrieved 




Haggard, H. W., Greenberg, L. A., & Turner, J. M. (1944). Physiological principles 
governing action of acetone together with determination of toxicity.  Journal of 
Industrial Hygiene and Toxicology, 26(5), 133-151. 
 
International Organization of Standardization/International Electrotechnical Commission. 
(2005). ISO/IEC 17025 - General requirements for the competence of testing and 
calibration laboratories (2
nd
 ed.).  Geneva, Switzerland: ISO. 
 
James, S. H. & Nordby, J. J. (Eds.). (2005).  Forensic Science: An Introduction to 
Scientific and Investigative Techniques (2nd ed.). New York: CRC Press. 
 
Jones, A. W., Sagarduy, A., Ericsson, E., & Arnqvist, H. J. (1993).  Concentrations of 
acetone in venous blood samples from drunk drivers, type-I diabetic outpatients, 
and healthy blood donors.  Journal of Analytical Toxicology. 17(3), 182-185. 
 
Kalapos, M. P. (2003).  On the mammalian acetone metabolism: from chemistry to 
clinical applications.  Biochimica et Biophysica Acta.  1621(2), 122-139. 
 
Kalapos, M. P. (2007).  Possible mechanism for the effect of ketogenic diet in cases of 
uncontrolled seizures: The reconsideration of acetone theory. Medical 
Hypotheses. 68(6), 1382-1388. 
 
 58 
Kalra, A., Tugcu, N., Cramer, S. M., & Garde, S.  (2001).  Salting-in and salting-out of 
hydrophobic solutes in aqueous salt solutions.  Journal of Physical Chemistry B.  
105(27), 6380-6386.  
 
Kolb, B., & Ettre, L. S. (2006).  Static Headspace-Gas Chromatography: Theory and 
Practice.  Hoboken, NJ: John Wiley & Sons, Inc. 
 
Koplow, L. (2006, June 24).  Scientific defenses that may be available in Arizona DUI 
cases.  Message posted to http://duiblog.arizonaduicenter.com/tags/defense/ 
 
Legacy Laboratory Services. (2007). 2007-2008 Guide to Laboratory Services. Portland, 
OR: Legacy Health System. 
 
Levine, B. (Ed.). (2006).  Principles of Forensic Toxicology (2nd ed.). Washington, DC: 
American Association for Clinical Chemistry. 
 
Lewis, R. J., Johnson, R. D., Angier, M. K., & Vu, N. T. (2004).  Ethanol formation in 
unadulterated postmortem tissues.  Forensic Science International.  146, 17-24. 
 
Likhodii, S. S., Serbanescu, I., Cortez, M. A., Murphy, P., Carter Snead III, O., & 
McIntyre Burnham, W.  (2003).  Anticonvulsant properties of acetone, a brain 
ketone elevated by the ketogenic diet.  Annals of Neurology. 54(2), 219-226. 
 
Linde Group. (2008). Gas Chromatography. Retrieved June 1, 2009, from Linde Gases 
Division Web site: http://hiq.linde-
gas.com/international/web/lg/spg/like35lgspg.nsf/docbyalias/anal_gaschrom 
 
Martinez, M. A., & Ballesteros, S. (2006). An unusual case of drug-facilitated sexual 
assault using aromatic solvents.  Journal of Analytical Toxicology, 30(7), 449-
453. 
 
McCarver-May, D. G., & Durisin, L. (1997). An accurate, automated, simultaneous gas  
chromatographic headspace measurement of whole blood ethanol and 
acetaldehyde for human in vivo studies. Journal of Analytical Toxicology, 21(2), 
134-141. 
 
Miekisch, W., Schubert, J. K., Vagts, D. A., & Geiger, K. (2001). Analysis of Volatile 
Disease Markers in Blood. Clinical Chemistry. 47, 1053-1060. 
 
Moeller, M. R., Steinmeyer, S., & Kraemer, T. (1998).  Determination of drugs of abuse 
in blood. Journal of Chromatography B, 713, 91-109. 
 
Morris-Kukoski, C., Jagerdeo, E., Schaff, J. E., & LeBeau, M. A.  (2007). Ethanol 
analysis from biological samples by dual rail robotic autosampler.  Journal of 
Chromatography B, 850(1-2), 230-235. 
 
 59 
National Institute on Drug Abuse.  (2009).  NIDA infofacts: inhalants.  Retrieved June 
25, 2009, from NIDA Web site: http://www.nida.nih.gov/infofacts/inhalants.html 
 
O’Neil, M. J., Smith, A., Heckelman, P. E., & Obenchain, Jr., J. R. (Eds.). (2001).  Merck 
Index . Whitehouse Station, NJ: Merck & Co. 
 
Oregon State Police Forensic Services Division.  (2008). Blood alcohol procedures 
manual (Revision 12).  Unpublished manuscript. 
 
Ramsey, J. D., & Flanagan R. J. (1982). Detection and identification of volatile organic 
compounds in blood by headspace gas chromatography as an aid to the diagnosis 
of solvent abuse. Journal of Chromatography, 240(2), 423-444. 
 
Ramu, A., Rosenbaum, J., & Blaschke, T. F. (1978).  Disoposition of acetone following 
acute acetone intoxication.  Western Journal of Medicine, 129(5), 429-432. 
 
Restek Corporation. (1999). GC analysis of commonly abused inhalants in blood using 
RTX-BAC1 and RTX-BAC2 columns (Restek Clinical/Forensic Applications Note 
No. 59548).  Bellafonte, PA: Resktek Corporation. 
 
Saferstein, R. (2007).  Criminalistics: An Introduction to Forensic Science (9th ed.). 
Upper Saddle River, New Jersey: Pearson Education, Inc. 
 
Singer, P. S., & Jones, G. R. (2006). An unusual autoerotic fatality associated with 
chloroform inhalation. Journal of Analytical Toxicology, 30(3), 216-218. 
 
Skoog, D. A., Holler, F. J., & Crouch, S. R. (2007).  Principles of Instrumental Analysis 
(6
th
 ed). Belmont, CA: Thomson Brooks/Cole. 
 
Streete, P. J., Ruprah, M., Ramsey, J.D., & Flanagan, N.J. (1992).  Detection and 
identification of volatile substances by headspace capillary gas chromatography to 
aid the diagnosis of acute poisoning.  Analyst.  117(7), 1111-1127. 
 
Sulway, M. J., & Malins, J. M. (1970).  Acetone in diabetic ketoacidosis.  Lancet, 1, 736-
740. 
 
United States Public Health Service.  (1994). Toxicological Profile: Acetone. Retrieved 
November 8, 2008, from Agency for Toxic Substances and Disease Registry Web 
site: http://www.atsdr.cdc.gov/toxprofiles/tp21-c1.pdf 
 
Utah Public Health Laboratories Bureau of Forensic Toxicology.  (2008). Volatiles in 
biological specimens by dual headspace gas chromatography. Retrieved June 11, 




Verstraete, A. G. (2004). Detection times of drugs of abuse in blood, urine, and oral fluid. 
Therapeutic Drug Monitoring.  26, 200-205. 
 
Virginia Department of Forensic Science.  (2009). Toxicology Procedures Manual.  




Wise, R. A.  (1996).  Neurobiology of addiction.  Current Opinion in Neurobiology.  
6(2), 243-251. 
 
Zhu, J. Y., & Chai, X. S. (2006).  Some recent developments in headspace gas 
chromatography. Current Analytical Chemistry, 1, 79-83. 
 
Zuba, D., Parczewski A., & Reichenbacher, M. (2002).  Optimization of solid-phase 
microextraction conditions for gas chromatographic determination of ethanol and 





Susan Lynn Talbert 
 
Candidate for the Degree of 
 
Master of Science 
 
 
Thesis:    QUANTITATIVE ANALYSIS OF VOLATILES IN BLOOD VIA 
HEADSPACE GAS CHROMATOGRAPHY/ FLAME IONIZATION 
DETECTION 
 








Education:   Graduated from Roseburg Senior High School in Roseburg, 
Oregon, in June 2007. 
 
 Received Bachelor of Science in Chemistry degree from 
Southern Oregon University in Ashland, Oregon, in June 2007.   
 
 Completed the requirements for the degree of Master of Science 
in Forensic Toxicology at Oklahoma State University - Center 
for Health Sciences in Tulsa, Oklahoma, in July 2009. 
  
 
Experience:   Worked as an unpaid Forensic Toxicology intern at the Oregon 
State Police, Portland Metropolitan Forensic Laboratory in 
Clackamas, Oregon, from February 2008 to May 2008, and 













Name: Susan Lynn Talbert                                 Date of Degree: July, 2009  
 
Institution: Oklahoma State University - CHS        Location: Tulsa, Oklahoma 
 
Title of Study: QUANTITATIVE ANALYSIS OF ACETONE IN BLOOD VIA 
HEADSPACE GAS CHROMATOGRAPHY/ FLAME IONIZATION 
DETECTION 
 
Pages in Study: 60                                 Candidate for the Degree of Master of Science 
Major Field: Forensic Toxicology 
 
Scope and Method of Study:  The purpose of this research project was to develop and 
validate a method for the quantitation of acetone in blood using Headspace Gas 
Chromatography with Flame Ionization Detection.  The following items were 
included in the development: preparation of standards and positive controls, 
testing the necessity of using salts, establishment of a suitable internal standard 
concentration, determination of an appropriate sample size, limit of detection 
calculation, establishing the linear dynamic range, testing for carryover effects, 
method validation including case samples, and checking the stability of samples 
containing acetone.  
 
Findings and Conclusions:  The blood-acetone quantitation method was successfully 
developed and validated.  Standards and controls were accurate and precise and 
yielded linear results.  The addition of salt to sample vials was deemed 
unnecessary.  An internal standard concentration of 0.05% (v/v) n-propanol in 
water and a sample size of 0.25 mL were found to be suitable.  The limit of 
detection was calculated to be 0.333 mg/dL while the limit of quantitation was 
calculated to be 0.816 mg/dL.  However, quantitations were inaccurate below 1.0 
mg/dL and blood-acetone concentrations above 250.0 mg/dL are not generally 
encountered.  Therefore, an administrative linear dynamic range was set from 1.0 
to 250.0 mg/dL.  No carryover between samples occurred.  Interday and 
interindividual variations were 6.93 and 0.77%, respectively.    When checking 
the stability of samples containing acetone, time accounted for 97.7% variation 
while temperature only accounted for 0.22% variation.   
